Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in
clinical practice. One of its most devastating complications is the development of …

Background: In the last decades, interventional cardiology has received fast and wide
implementation as an effective alternative treatment to surgery for several congenital and …

Percutaneous left atrial appendage occlusion (LAAO) with the Watchman device (Boston
Scientific, Natick, Massachusetts) is currently conducted under fluoroscopic and …

Transcatheter left atrial appendage (LAA) closure is an alternative to long-term
anticoagulation therapy in selected patients with nonvalvular atrial fibrillation who have an …

Accurate assessment of the left atrial appendage (LAA) is important for pre-procedure
planning when utilizing device closure for stroke reduction. Sizing is traditionally done with …

Introduction Percutaneous left atrial appendage (LAA) occlusion is an emerging treatment
option for patients with non-valvular atrial fibrillation who cannot tolerate oral …

Aim To investigate the role of cardiac CT angiography (CCTA) in predicting optimal left atrial
appendage (LAA) occluder size and procedure outcome. Methods and results Thirty-six …

Aims Percutaneous left atrial appendage occlusion (LAAO) with the Amplatzer Cardiac Plug
(ACP) emerged as a valid alternative in patients with a formal contraindication to oral …

Background Computed tomography (CT) imaging has not been systematically studied for
predicting vascular complications during transcatheter aortic valve replacement (TAVR) …

Background The adequate device size selection for left atrial appendage closure is crucial to
ensuring adequate implantation and for avoiding the need for multiple attempts that increase …